Analysis of diltiazem and its related substances by HPLC and HPLC/MS.

J Pharm Biomed Anal

Dipartimento Studi Farmaceutici, Università degli Studi di Roma La Sapienza, Piazzale Aldo Moro 5, Rome 00185, Italy.

Published: April 2005

Diltiazem (DTZ) is an optically active calcium channel blocker having a benzodiazepine structure. The drug used in therapy is (+)-cis-diltiazem with configuration (2S,3S). To describe the analytical profile of DTZ different stationary phases (RP-18, RP-8, monolithic support) were tested. The best separation of DTZ from A, B, E and F was obtained using as stationary phase a RP-8 or a monolithic RP-18. The characterization of impurities was carried out using two analytical systems, HPLC and HPLC/MS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2004.11.050DOI Listing

Publication Analysis

Top Keywords

hplc hplc/ms
8
dtz stationary
8
rp-8 monolithic
8
analysis diltiazem
4
diltiazem substances
4
substances hplc
4
hplc/ms diltiazem
4
diltiazem dtz
4
dtz optically
4
optically active
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!